Ketanserin

Ketanserin
Clinical data
ATC code	C02KD01 (WHO) ;
Identifiers
CAS Number	74050-98-9;
PubChem CID	3822;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C22FN3O3
Molar mass	395.43 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Ketanserin is a serotonin receptor antagonist. It has the highest affinity for the serotonin 5-HT_2A receptor, but also binds less potently to the 5-HT_2C, 5-HT_2B, 5-HT_1D, alpha-adrenergic, and dopamine receptors. With tritium radioactively labeled ketanserin is used as a radioligand for the serotonin 5-HT_2A receptor, e.g. in receptor binding assays.

Ketanserin was discovered at Janssen Pharmaceutica in 1980.

v t e Antihypertensives (C02) and diuretics (C03)
Sympatholytic agents	Template:Navbox subgroup
Vasodilators	Diazoxide • hydrazinophthalazine (Hydralazine, Dihydralazine, Endralazine, Cadralazine) • Minoxidil • Nitroprusside • Phentolamine
Other antihypertensives	serotonin antagonist (Ketanserin) • endothelin receptor antagonist (Bosentan, Ambrisentan, Sitaxsentan) • MAOI (Pargyline) • THI (Metirosine)
Diuretics	Template:Navbox subgroup

Clinical data

ATC code	C02KD01 (WHO)
Identifiers
CAS Number	74050-98-9
PubChem CID	3822
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₂₂FN₃O₃
Molar mass	395.43 g/mol